Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LIPSTIC teicoplanin pharmacokinetic/pharmacodynamic study in children
2012-005738-12Phase 4Completed
- Sponsor
- Alder Hey Children's NHS Foundation Trust
- Start
- Jan 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of teicoplanin in Gram-positive bacterial infection, late-onset neonatal sepsis (LONS), central line-associated bloodstream infection (CLABSI) and 1 more, sponsored by Alder Hey Children's NHS Foundation Trust. Started Jan 2013; status: completed.
02
Drugs
teicoplanin
03
Conditions
Gram-positive bacterial infectionlate-onset neonatal sepsis (LONS)central line-associated bloodstream infection (CLABSI)ventilator-associated pneumonia (VAP)
Beyond the preview
Go deeper on 2012-005738-12.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-005738-12.